You are here

Development of a hemostatic wound dressing incorporating lyophilized platelets

Award Information
Agency: Department of Defense
Branch: Army
Contract: W81XWH-05-C-0057
Agency Tracking Number: O2-0347
Amount: $750,000.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: OSD04-H17
Solicitation Number: 2004.3
Timeline
Solicitation Year: 2004
Award Year: 2005
Award Start Date (Proposal Award Date): 2005-12-07
Award End Date (Contract End Date): 2007-12-07
Small Business Information
9430 Key West Avenue, Suite 210
Rockville, MD 20850
United States
DUNS: 137192840
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 David Ho
 Director of Hematology
 (301) 424-8344
 dho@adlyfe.com
Business Contact
 Richard Cliff
Title: COO
Phone: (301) 424-8344
Email: rcliff@adlyfe.com
Research Institution
N/A
Abstract

Blood loss due to uncontrolled hemorrhage is a major contribution to at least 90% of the combat death before reaching the field hospital. The ability to control heavy bleeding in the injured soldier is critical and will vastly improve the survival outcome in the theater. Furthermore, complications from uncontrolled bleeding in the microvasculature contribute significantly to increased morbidity. Finally, disruption of the vasculature during trauma can limit healing and soft tissue repair and regenerative phases once bleeding has subsided. Our goal is to address these critical aspects of combat casualty care, providing first echelon care that will have significant impact on acute events as well as improved outcome late into the time course of treatment and recovery. Our approach to developing next generation hemostatic products for combat casualty care is to exploit the natural properties of platelets which contain both hemostatic and healing properties.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government